These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15632813)

  • 1. Satisfaction with treatment and prevalence of discomfort after external electrical cardioversion.
    Pita-Fernández S; Fariñas-Garrido MP; Suárez-Fontaíña EM; Amor-Cambón J; Sánchez-Suárez I; Rúa-Pérez MC; Varela-Tomé MD; Pértega-Díaz S
    J Cardiovasc Nurs; 2005; 20(1):49-55. PubMed ID: 15632813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidents of cutaneous alteration secondary to external electrical cardioversion].
    Alconero Camarero AR; Casaus Pérez M; Gutiérrez Caloca N
    Enferm Intensiva; 2006; 17(4):163-72. PubMed ID: 17194414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
    Arnar DO; Danielsen R
    Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of the effect of biphasic or monophasic waveform on the incidence and severity of cutaneous burns following external direct current cardioversion.
    Ambler JJ; Deakin CD
    Resuscitation; 2006 Dec; 71(3):293-300. PubMed ID: 16996194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
    Larsen MT; Lyngborg K; Pedersen F; Corell P
    Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.
    Houghton AR; Sharman A; Pohl JE
    Br J Gen Pract; 2000 Sep; 50(458):710-1. PubMed ID: 11050786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Verwer R; Lie KI
    Am J Cardiol; 1991 Jul; 68(1):41-6. PubMed ID: 2058558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
    Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
    J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter.
    Lobo R; Jaffe AS; Cahill C; Blake O; Abbas S; Meany TB; Hennessy T; Kiernan TJ
    Am J Cardiol; 2018 Jan; 121(2):188-192. PubMed ID: 29221605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early experience of nurse-led elective DC cardioversion.
    Quinn T
    Nurs Crit Care; 1998; 3(2):59-62. PubMed ID: 9883163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events.
    Grimm RA; Stewart WJ; Arheart K; Thomas JD; Klein AL
    J Am Coll Cardiol; 1997 Mar; 29(3):582-9. PubMed ID: 9060897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
    Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
    Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
    Hohnloser SH; Cappato R; Ezekowitz MD; Evers T; Sahin K; Kirchhof P; Meng IL; van Eickels M; Camm AJ;
    Europace; 2016 Feb; 18(2):184-90. PubMed ID: 26487668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation.
    Poterucha JT; Egbe AC; Johnson JN; Niaz T; Wackel PL; Cannon BC; Eidem BW; Cetta F
    Congenit Heart Dis; 2016 Dec; 11(6):578-583. PubMed ID: 27030521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and severity of cutaneous burns following external DC cardioversion.
    Ambler JJ; Sado DM; Zideman DA; Deakin CD
    Resuscitation; 2004 Jun; 61(3):281-8. PubMed ID: 15172706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender Differences in Patients with Atrial Fibrillation Undergoing Electrical Cardioversion.
    Alegret JM; Viñolas X; Martínez-Rubio A; Pedrote A; Beiras X; García-Sacristán JF; Crespo-Mancebo F; Ruiz-Mateas F
    J Womens Health (Larchmt); 2015 Jun; 24(6):466-70. PubMed ID: 25978301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
    Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
    Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter.
    Xavier Scheuermeyer F; Grafstein E; Stenstrom R; Innes G; Poureslami I; Sighary M
    Acad Emerg Med; 2010 Apr; 17(4):408-15. PubMed ID: 20370780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.
    Goette A; Kwong WJ; Ezekowitz MD; Banach M; Hjortshoj SP; Zamoryakhin D; Lip GYH
    Europace; 2018 Dec; 20(12):1936-1943. PubMed ID: 29947751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.